Systemic inhibition of PTPN22 augments anticancer immunity

Won Jin Ho(Johns Hopkins University), Elizabeth M. Jaffee(Johns Hopkins University)

Journal of Clinical Investigation

July 20, 2021

10.1172/jci146950

Cited by 52

Related Papers

Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

|The Journal of Experimental Medicine|2004|349

Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer

|PLoS ONE|2011|183

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways

|Genome biology|2021|63